MyMedR

Displaying all 4 publications

Abstract:

Sort:

A new species of genus Nishada Moore, 1878 (Lepidoptera, Erebidae, Arctiinae) from India

Joshi R, Kirti JS, Singh N

Zootaxa, 2016 Oct 28;4179(1):128-132.
PMID: 27811698 DOI: 10.11646/zootaxa.4179.1.10

Genus Nishada Moore (1878) was proposed as a monotypic genus, under subfamily Lithosiinae, family Lithosiidae (now Lithosiini), including only Nishada flabrifera Moore (1878) from Calcutta (now as Kolkata), India. The genus is distributed from China to India, Thailand, Malaysia and up to Australia. The Indian fauna of Nishada is reported from North-East Himalayas, West Bengal (Kolkata) and South India. Members of this genus are unmarked, yellow to brown with short and broad wings. Genus Nishada has been taxonomically dealt by many authors but awaits thorough revision.
HISTORY: Hampson (1900) included a total of ten species: Nishada niveola Hampson, 1900, Nishada syntomioides (Walker, 1862), Nishada impervia (Walker, 1865), Nishada marginalis (Felder 1875), Nishada tula Swinhoe, 1900, Nishada nodicornis (Walker 1862), Nishada rotundipennis (Walker 1862), Nishada flabrifera Moore, 1878, Nishada sambara (Moore 1859) and Nishada xantholoma (Snellen 1879). Swinhoe (1902) and Hampson (1911) then described two new species, Nishada melanistis and Nishada brunneipennis, respectively, followed by Rothschild (1912, 1913) who described a further seven new species, Nishada brunnea, Nishada flavens, Nishada testacea, Nishada griseoflava, Nishada fuscofascia, Nishada louisiadensis and Nishada aurantiaca, bringing the total to 19 species. Strand (1922) catalogued only 13 of these species in Nishada, transferring N. brunnea and N. fuscofascia to genus Scoliacma Meyrick (1886); N. testacea, N.griseoflava and N. louisiadensis Rothschild to Eilema Hübner (1819) and synonymising N. flavens with N. sambara. Next, Matsumura (1927) described N. formosibia, followed by two more species, N. aureocincta Debauche, 1938 and N. benjaminea Roepke, 1946. Holloway (2001) synonymised N. nodicornis with N. rotundipennis and added the description of a new subspecies, Nishada chilomorpha adunca Holloway, 2001 from Borneo, indicating a distributional range as far as North East India. The nominotypical subspecies, N. c. chilomorpha was suggested to be restricted to its type locality of Java. Bucsek (2012) added Nishada cameronensis, Dubatolov & Bucsek (2013) described Nishada schintlmeisteri and Bucsek (2016) described Nishada temenggora. So, at present, Nishada comprises19 species, of which three are known from India (Singh et al. 2014). Herein, we describe one further species, Nishada pseudochilomorpha Joshi & Singh sp. nov., from Jatinga (Assam, India). In addition, new distributional records are reported for N. flabrifera.
Fulltext Radiotherapy in locally advanced cancer of the cervix

Biswal BM, Rath GK, Joshi RC, Mohanti BK, Ganesh T, Singh R

Med J Malaysia, 1998 Mar;53(1):30-6.
PMID: 10968134

Radical radiotherapy is considered as the treatment of choice in locally advanced cancer cervix. In late stages radiotherapy produce optimum palliation and to some extent cure. Three hundred cases of cancer cervix (stage I-IV) comprising stage-I (7), stage-II (144), stage-III (145) and stage IV (4) were evaluated and treated with radiotherapy between April 1990 to July 1994. FIGO stage IB, IIA and IIB (early), were treated with predominant intracavitary radiotherapy (34 Gy X 2 fractions; within one week) followed by external pelvic radiotherapy to a dose of 36 Gy in 18 fractions; treating 200 cGy per fraction, 5 days a week. The late stage (stage-IIB, IIIA and IIIB, IVA) of disease were managed with initial external radiotherapy to a dose of 50 Gy, followed by a single intracavitary dose of 30 Gy to point-A. The median follow up was 33 months (range 12-72 months). The tumor volume less than 100 cc were associated with better survival than volume more than 100 cc (p < 0.05). The five year actuarial survival was 83%, 68% and 58% respectively in FIGO stage I-III disease. There were 0.33% and 2.6% late grade-III bladder and rectal complications. Our experience shows effectiveness of radiotherapy in the management of locally advanced cancer of the cervix.
Fulltext Innovative Approaches to Hypertension Control in Low- and Middle-Income Countries

Vedanthan R, Bernabe-Ortiz A, Herasme OI, Joshi R, Lopez-Jaramillo P, Thrift AG, et al.

Cardiol Clin, 2017 Feb;35(1):99-115.
PMID: 27886793 DOI: 10.1016/j.ccl.2016.08.010

Elevated blood pressure, a major risk factor for ischemic heart disease, heart failure, and stroke, is the leading global risk for mortality. Treatment and control rates are very low in low- and middle-income countries. There is an urgent need to address this problem. The Global Alliance for Chronic Diseases sponsored research projects focus on controlling hypertension, including community engagement, salt reduction, salt substitution, task redistribution, mHealth, and fixed-dose combination therapies. This paper reviews the rationale for each approach and summarizes the experience of some of the research teams. The studies demonstrate innovative and practical methods for improving hypertension control.
Evidence for the Higgs Boson Decay to a Z Boson and a Photon at the LHC

Aad G, Abbott B, Abeling K, Abicht NJ, Abidi SH, Aboulhorma A, et al.

Phys Rev Lett, 2024 Jan 12;132(2):021803.
PMID: 38277607 DOI: 10.1103/PhysRevLett.132.021803

The first evidence for the Higgs boson decay to a Z boson and a photon is presented, with a statistical significance of 3.4 standard deviations. The result is derived from a combined analysis of the searches performed by the ATLAS and CMS Collaborations with proton-proton collision datasets collected at the CERN Large Hadron Collider (LHC) from 2015 to 2018. These correspond to integrated luminosities of around 140 fb^{-1} for each experiment, at a center-of-mass energy of 13 TeV. The measured signal yield is 2.2±0.7 times the standard model prediction, and agrees with the theoretical expectation within 1.9 standard deviations.